380 related articles for article (PubMed ID: 37178431)
21. Potential role of TRAIL in the management of autoimmune diabetes mellitus.
Bernardi S; Norcio A; Toffoli B; Zauli G; Secchiero P
Curr Pharm Des; 2012; 18(35):5759-65. PubMed ID: 22726118
[TBL] [Abstract][Full Text] [Related]
22. Regulatory and policy issues for T1DM immunotherapy.
Fleming A
Hum Vaccin; 2011 Jan; 7(1):50-5. PubMed ID: 21242726
[TBL] [Abstract][Full Text] [Related]
23. T-lymphocyte recognition of beta cells in type 1 diabetes: clinical perspectives.
Boitard C
Diabetes Metab; 2013 Dec; 39(6):459-66. PubMed ID: 24139825
[TBL] [Abstract][Full Text] [Related]
24. Type I Diabetes Pathoetiology and Pathophysiology: Roles of the Gut Microbiome, Pancreatic Cellular Interactions, and the 'Bystander' Activation of Memory CD8
Anderson G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834709
[TBL] [Abstract][Full Text] [Related]
25. Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review.
Tan T; Xiang Y; Chang C; Zhou Z
Clin Rev Allergy Immunol; 2014 Oct; 47(2):234-43. PubMed ID: 25086642
[TBL] [Abstract][Full Text] [Related]
26. Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in development.
Vudattu NK; Herold KC
Expert Opin Biol Ther; 2014 Mar; 14(3):377-85. PubMed ID: 24517093
[TBL] [Abstract][Full Text] [Related]
27. [Insulin secretion in the early phase of type 1 diabetes mellitus (T1DM) and new hopes for maintaining it through therapy].
Żalińska M; Szmigiero-Kawko M; Brandt A; Trzonkowski P; Myśliwiec M
Pediatr Endocrinol Diabetes Metab; 2016; 22(3):. PubMed ID: 28633161
[TBL] [Abstract][Full Text] [Related]
28. Immune intervention for type 1 diabetes mellitus.
Skyler JS
Int J Clin Pract Suppl; 2011 Feb; (170):61-70. PubMed ID: 21323814
[TBL] [Abstract][Full Text] [Related]
29. Lessons on autoimmune diabetes from animal models.
Yang Y; Santamaria P
Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy-based strategies for the treatment of autoimmune diabetes: searching for the cure.
Phillips BE; Trucco M
Curr Pharm Des; 2011; 17(29):3217-23. PubMed ID: 21864264
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of otelixizumab use in new-onset type 1 diabetes mellitus.
Guglielmi C; Williams SR; Del Toro R; Pozzilli P
Expert Opin Biol Ther; 2016 Jun; 16(6):841-6. PubMed ID: 27145230
[TBL] [Abstract][Full Text] [Related]
32. The potential role of dendritic cells in the therapy of Type 1 diabetes.
Lee CN; Lew AM; Wu L
Immunotherapy; 2013 Jun; 5(6):591-606. PubMed ID: 23725283
[TBL] [Abstract][Full Text] [Related]
33. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.
Azam A; Eisenbarth GS
Expert Opin Biol Ther; 2004 Oct; 4(10):1569-75. PubMed ID: 15461568
[TBL] [Abstract][Full Text] [Related]
34. Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement.
Wan XX; Zhang DY; Khan MA; Zheng SY; Hu XM; Zhang Q; Yang RH; Xiong K
Front Endocrinol (Lausanne); 2022; 13():859638. PubMed ID: 35370989
[TBL] [Abstract][Full Text] [Related]
35. Analysis of immune cell components and immune-related gene expression profiles in peripheral blood of patients with type 1 diabetes mellitus.
Lin J; Lu Y; Wang B; Jiao P; Ma J
J Transl Med; 2021 Jul; 19(1):319. PubMed ID: 34311758
[TBL] [Abstract][Full Text] [Related]
36. Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).
Roep BO; Thomaidou S; van Tienhoven R; Zaldumbide A
Nat Rev Endocrinol; 2021 Mar; 17(3):150-161. PubMed ID: 33293704
[TBL] [Abstract][Full Text] [Related]
37. Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes.
Kashalikar P; Desai S; Sanap A; Shekatkar M; Bhonde R
Recent Adv Inflamm Allergy Drug Discov; 2023; 17(1):64-70. PubMed ID: 36415095
[TBL] [Abstract][Full Text] [Related]
38. Childhood diabetes mellitus: recent advances & future prospects.
Dejkhamron P; Menon RK; Sperling MA
Indian J Med Res; 2007 Mar; 125(3):231-50. PubMed ID: 17496353
[TBL] [Abstract][Full Text] [Related]
39. Type 1 diabetes mellitus and its oral tolerance therapy.
Mao RF; Chen YY; Zhang J; Chang X; Wang YF
World J Diabetes; 2020 Oct; 11(10):400-415. PubMed ID: 33133388
[TBL] [Abstract][Full Text] [Related]
40. Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications.
Zhang J; Xiao Y; Hu J; Liu S; Zhou Z; Xie L
Front Immunol; 2022; 13():999108. PubMed ID: 36275658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
